Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 6;12(1):15115.
doi: 10.1038/s41598-022-19393-0.

Study of gut microbiota alterations in Alzheimer's dementia patients from Kazakhstan

Affiliations

Study of gut microbiota alterations in Alzheimer's dementia patients from Kazakhstan

Aiym Kaiyrlykyzy et al. Sci Rep. .

Abstract

We have investigated the diversity and composition of gut microbiotas isolated from AD (Alzheimer's disease) patients (n = 41) and healthy seniors (n = 43) from Nur-Sultan city (Kazakhstan). The composition of the gut microbiota was characterized by 16S ribosomal RNA sequencing. Our results demonstrated significant differences in bacterial abundance at phylum, class, order, and genus levels in AD patients compared to healthy aged individuals. Relative abundance analysis has revealed increased amount of taxa belonging to Acidobacteriota, Verrucomicrobiota, Planctomycetota and Synergistota phyla in AD patients. Among bacterial genera, microbiotas of AD participants were characterized by a decreased amount of Bifidobacterium, Clostridia bacterium, Castellaniella, Erysipelotrichaceae UCG-003, Roseburia, Tuzzerella, Lactobacillaceae and Monoglobus. Differential abundance analysis determined enriched genera of Christensenellaceae R-7 group, Prevotella, Alloprevotella, Eubacterium coprostanoligenes group, Ruminococcus, Flavobacterium, Ohtaekwangia, Akkermansia, Bacteroides sp. Marseille-P3166 in AD patients, whereas Levilactobacillus, Lactiplantibacillus, Tyzzerella, Eubacterium siraeum group, Monoglobus, Bacteroides, Erysipelotrichaceae UCG-003, Veillonella, Faecalibacterium, Roseburia, Haemophilus were depleted. We have also found correlations between some bacteria taxa and blood serum biochemical parameters. Adiponectin was correlated with Acidimicrobiia, Faecalibacterium, Actinobacteria, Oscillospiraceae, Prevotella and Christensenellaceae R-7. The Christensenellaceae R-7 group and Acidobacteriota were correlated with total bilirubin, while Firmicutes, Acidobacteriales bacterium, Castellaniella alcaligenes, Lachnospiraceae, Christensenellaceae and Klebsiella pneumoniae were correlated with the level of CRP in the blood of AD patients. In addition, we report the correlations found between disease severity and certain fecal bacteria. This is the first reported study demonstrating gut microbiota alterations in AD in the Central Asian region.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Relative abundance of the bacterial types in the stool samples. Normal control (healthy controls), AD (individuals with Alzheimer's disease). (A) Phylum level, (B) class level, (C) genus level.
Figure 2
Figure 2
Violin plots of differentially abundant taxa between AD and healthy controls.
Figure 3
Figure 3
(A) α-diversity (Shannon, Simpson indexes) of fecal bacteria in individuals with Alzheimer's disease (AD) and normal controls. (B) β-diversity (weighted UniFrac distance) of fecal bacteria in individuals with Alzheimer's disease (AD) and healthy controls (Normal control). (C) The linear discriminant analysis (LDA) scores (LEfse plot). An LDA score (log 10) > 2 indicates a significantly different enrichment of bacteria taxa in the AD group (purple) compared to the control group (green). p phylum, c class, o order, f family, g genus, s species.
Figure 4
Figure 4
Correlation between adiponectin, C-reactive protein, total bilirubin, triglycerides, and differential bacterial taxa in AD and controls. ADPQ adiponectin, TBIL total bilirubin, CRP C-reactive protein, TRIG triglycerides.

References

    1. Prince M, Ali GC, Guerchet M, Prina AM, Albanese E, Wu YT. Recent global trends in the prevalence and incidence of dementia, and survival with dementia. Alzheimer's Res. Ther. 2016;8:1–3. doi: 10.1186/s13195-016-0188-8. - DOI - PMC - PubMed
    1. Alzheimer's Association. Thies W, Bleiler L. 2013 Alzheimer's disease facts and figures. Alzheimer's Dement. 2013;9(2):208–245. doi: 10.1016/j.jalz.2013.02.003. - DOI - PubMed
    1. Prince, M. J. et al.World Alzheimer Report 2015-the Global Impact of Dementia (Alzheimer’s Disease International, 2015) https://www.alz.co.uk/research/WorldAlzheimerReport2015.pdf.
    1. Tsoy RT, Turuspekova ST, Klipitskaya NK, Mereke A, Cumming RG. Prevalence of mild cognitive impairment among older people in kazakhstan and potential risk factors: A cross-sectional study. Alzheimer Dis. Assoc. Disord. 2019;33(2):136–141. doi: 10.1097/WAD.0000000000000298. - DOI - PubMed
    1. The Human Microbiome Project C. Huttenhower C, Gevers D, Knight R, Abubucker S, Badger JH, Chinwalla AT, et al. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207. doi: 10.1038/nature11234. - DOI - PMC - PubMed

Publication types

Substances